Doximity, Inc.
DOCSHealthcareNASDAQHealth Information Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframeDoximity, Inc. operates a digital platform for medical professionals in the United States. The company carries a $5.95B market cap, placing it firmly in the mid-cap category. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.
Market Cap
$5.95B
Beta
1.22
P/E (TTM)
39.28
P/E (Fwd)
21.43
EPS (TTM)
$0.85
EPS (Fwd)
$1.56
ROE
17.2%
ROA
10.9%
Cash
$687.8M
Total Debt
$9.7M
Free CF
$239.7M
52W Change
-51.3%
Annual Financials
Cash vs Debt
Where DOCS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, DOCS finished 32.14% above its 150-day moving average ($23.80) and 20.92% above its 200-day moving average ($26.01). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is DOCS overbought or oversold?
At the October 20, 2026 close, DOCS's RSI(14) was 74.1, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $687.8M in cash and $9.7M in debt, DOCS maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $239.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 17.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 10.9% further supports the picture of efficient asset utilization. Revenue has grown from $419.1M (2023) to $644.9M (2026), reflecting a 54% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Doximity, Inc. and its sector.